Quoin shareholders approve increase in shares from 100M to 5B; Sally Lawlor named new CFO

Quoin Pharmaceuticals, Ltd.

Shareholders approved amendment to increase authorized ordinary shares from 100,000,000 to 5,000,000,000 (50x).
Sally Lawlor appointed CFO effective Aug 18, 2025; base salary €380,000, bonus up to 50%, pension, health insurance.
Ms. Lawlor is the niece of CEO Dr. Michael Myers; prior roles at Sebela Pharma, Aptiv Plc, and KPMG.
Shareholders also approved new Compensation Policy and 2025 Equity Incentive Plan.
Prior CFO Gordon Dunn's last day was Aug 15, 2025; separation agreement pending.

item 5.07item 3.03item 5.02item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.